Stability studies of alprazolam tablets: effects of chemical interactions with some excipients in pharmaceutical solid preparations

An HPLC method was developed to determine the stability of alprazolam (AL) as a pure drug and in monodrug pharmaceutical tablets. The main degradation product of AL tablets was isolated and fully characterized as triazolaminoquinoleine (TAQ). For a quantitative evaluation of the excipient effects in the pharmaceutical formulations, a 2^k fractionated factorial design was applied in the preparation of the different samples. The kinetic of degradation of AL in each formulation was followed by UV spectrophotometry. It was found that excipients like CMC and magnesium stearate favour degradation, while the rate of the reaction is decreased when lactose and starch were used as excipients. A mechanism for the interactions of AL with some excipients is postulated that explains the observed results. Copyright © 2009 John Wiley & Sons, Ltd.     

心宁缓释片的质量标准研究

目的:建立心宁缓释片的质量标准控制方法.方法:采用TLC对丹参提取物、B草SFE-CO2萃取物进行定性鉴别,采用紫外分光光度法对制剂中总酚酸与总生物碱进行含量测定,采用HPLC法测定制剂中丹酚酸B、HJJ的含量及其释放度.结果:薄层色谱图斑点清晰,具有专属性.总丹酚酸、总生物碱、丹酚酸B、HJJ分别在2.5-25μg/mL、1.6-16μg/mL、0.88-11μg、0.08-0.8μg范围内线性关系良好,相关系数R分别为0.999 9、0.999 8、0.999 5、0.999 9,其平均回收率分别为98.26%、99.34%、97.34%、97.86%,RSD分别为2.1%、0.58%、0.95%、1.53%,累计释放率在2 h时约为25%、8 h时约75%、12 h时达94%以上.结论:该方法能准确可靠地进行定性、定量检测,能有效地控制心宁缓释片的质量.     

CPA矩阵法测定肺保三效片中六组分含量

本文采用ＣＰＡ矩阵法测定肺保三效片中六种组分的含量．计算程序采用ＢＡＳＩＣ语言编制．扑热息痛、苯妥英钠、咖啡因、茶碱、扑尔敏和盐酸麻黄碱的平均回收率和相对标准偏差分别为９６．１５％，０．７７％；９６．１５％，０．７２％；９６．４１％，０．６１％；９６．２２％，０．７１％；９６．１３％，０．７４％；９６．１６％，０．７７％．结果较满意．     

Characterization of factors affecting the release of low-solubility drug from prolonged release tablets

Diclofenac sodium (2-[(2,6-dichlorophenyl)amino]benzeneacetic acid monosodium salt) was investigated as a low-solubility drug and Naklofen^® retard prolonged release tablets, containing 100 mg of diclofenac sodium as a prolonged release lipophilic matrix system using factorial design approach. First, the solubility characteristics of diclofenac sodium in aqueous media with various ionic strengths, ionic compositions and pH in the range of 1-8 were determined. The obtained results showed that the solubility of diclofenac sodium depends mainly on pH of the aqueous medium and less on the composition and ionic strength of the medium. Next, the estimation of the effects of six different factors (type of the dissolution apparatus, rotation speeds of the stirring elements, pH, ionic strengths of dissolution medium, the applied salt, and the producer of the on-line connected dissolution apparatus and UV spectrophotometer) on the release of diclofenac sodium, using the two-level six-factorial design was investigated. It was found that rotation speeds of the stirring elements, pH, and ionic strengths of the dissolution medium have a significant impact on the drug release and should be further followed in future drug release analyses. The advantages of the factorial design approach are obvious in this work. It is a very economic way of obtaining the maximum amount of information in a short period of time, especially in the case of prolonged release formulations where each experiment requires at least 24 h.     

Determination and Validation of an LC Method for Fluvoxamine in Tablets

A new, simple, rapid and specific reversed-phase high-performance liquid chromatography (HPLC) method was developed and validated for the determination of fluvoxamine in pharmaceutical dosage forms. The HPLC separation was achieved on a C₁₈ μ-Bondapack column (250 mm × 4.6 mm) using a mobile phase of acetonitrile–water (80:20, v/v) at a flow rate of 1 mL min⁻¹. Proposed method is based on the derivatization of fluvoxamine with 1,2-naphthoquinone-4-sulphonic acid sodium salt (NQS) in borate buffer of pH 8.5 to yield a orange product. The HPLC method is based on measurement of the derivatized product using UV-visible absorbance detection at 450 nm. The method was validated for specificity, linearity, precision, accuracy, robustness. The degree of linearity of the calibration curves, the percent recoveries of fluvoxamine, the limit of detection and quantification, for the HPLC method were determined. The assay was linear over the concentration range of 45–145 ng mL⁻¹ (r = 0.9999). Limit of detection and quantification for fluvoxamine were 15 and 50 ng mL⁻¹, respectively. The results of the developed procedure (proposed method) for fluvoxamine content in tablets were compared with those by the official method. The method was found to be simple, specific, precise, accurate, reproducible and robust.     

LC Determination of Gemfibrozil in Tablets

A simple, selective, precise and accurate reversed phase-HPLC assay for analysis of gemfibrozil in tablets was developed and validated. Separation and quantification were achieved on a Phenomenex C₁₈ column under isocratic conditions using a mobile phase (methanol:water, 80:20, v/v) maintained at 1.1 mL min⁻¹. UV-detection was at 280 nm. Atorvastatin was selected as an internal standard. The standard curves were linear over the range of 0.5–3.0 μg mL⁻¹ (r > 0.999). The limits of detection and quantification were 0.20 and 0.51 μg mL⁻¹, respectively. The recoveries for gemfibrozil were above 99.01%. The intra-day and inter-day precision (RSD) for gemfibrozil were below 1.74 and 1.83%, respectively. No chromatographic interferences from the tablet excipients were found. The results of the developed procedure in tablets were compared with those of the reference method to assess gemfibrozil content. Statistical comparison of the results with the reference method using spectrofluorimetric method showed excellent agreement and proved no significant difference in accuracy and precision. This HPLC method is fast and simple for the analysis of gemfibrozil in pharmaceutical preparations.     

卡托普利缓释片释放过程的灰色数学模型

目的:用灰色理论研究卡托普利缓释片的体外释放过程.方法:采用羧甲基纤维素钠为骨架材料制备缓释片,通过体外释放试验,根据灰色数学模型,预测卡托普利缓释片的体外释放过程.结果:预测值与实测值的平均绝对误差E为0.532,平均相对误差为1.059%.结论:为卡托普利缓释片的临床合理化用药提供了理论依据.     

Determination of iodine anion in dried kelp and iodized throat tablets by reversed-phase ion-pair liquid chromatography with direct UV detection

Summary In this paper, the amount of iodine anion in dried kelp and iodized throat tablets was determined by reversed-phase ion-pair chromatography. A 300×4 mm I.D. columns packed with -Bondapak-C18 (5 m) was used and distilled water containing 10 mmol/l trimethylphenyl ammonium bromide was used as the eluent. UV detection at 231 nm was selected to monitor the iodine anion.     

胶束电动毛细管色谱法测定消糖灵中的优降糖

 以甲氧苄氨嘧啶为内标,采用胶束电动毛细管色谱法分离测定了新药消糖灵中的优降糖。电泳条件：以25 mmol/L硼砂-30 mmol/L十二烷基硫酸钠（pH 9.0）为电泳介质,未涂层石英毛细管（50 μm i.d.×39.5 cm,有效分离长度34.8 cm）为分离通道,压力进样(68.95 kPa.s),17 kV恒压电泳（28 ℃）,检测波长228 nm。优降糖在14 min内与其他成分得到很好分离,且质量浓度为25 mg/L～275 mg/L时,优降糖可进行定量分析,加标回收率为(100.6±1.4)%。方法简便、快速,结果准确,重现性好,可用于优降糖复方制剂的质量控制。     

膜富集-可见漫反射光谱法测定池塘水和维生素B_(12)药片中痕量钴

1-(2-吡啶偶氮)-2-萘酚与钴离子生成暗绿色的络合物,反应后将其过滤到膜上,测得膜表面漫反射光谱,据此提出了膜富集-可见漫反射光谱法测定池塘水和维生素B12药片中痕量钴的方法。钴的质量浓度在0.2~3.0μg·L-1和3.0~10.0μg·L-1范围内与其吸光度呈线性关系,检出限(3s/k)为0.093μg·L-1。方法用于池塘水和维生素B12药片的分析,加标回收率在96.7%~105%之间,测定值的相对标准偏差在1.4%~2.9%之间。